Recent progress in pancreatic cancer

2013/07/15 by Christopher L. Wolfgang, Joseph M. Herman, Daniel A. Laheru +5 · 942 citations
Biochemistry, Genetics and Molecular Biology · Medicine · #Cancer #Cancer Genomics and Diagnostics #Computer science #Intensive care medicine #Internal medicine #Medicine #Multidisciplinary approach #Pancreas #Pancreatic and Hepatic Oncology Research #Pancreatic cancer #Political science #Radiation therapy #Renal cell carcinoma treatment #SAFER

paper · pdf · doi:10.3322/caac.21190

published in CA A Cancer Journal for Clinicians 63(5), 318-348 (Wiley)

openalex publication_date 2013/07/15 · openalex created_date 2025/10/10 · openalex updated_date 2026/08/01

Abstract

Pancreatic cancer is currently one of the deadliest of the solid malignancies. However, surgery to resect neoplasms of the pancreas is safer and less invasive than ever, novel drug combinations have been shown to improve survival, advances in radiation therapy have resulted in less toxicity, and enormous strides have been made in the understanding of the fundamental genetics of pancreatic cancer. These advances provide hope but they also increase the complexity of caring for patients. It is clear that multidisciplinary care that provides comprehensive and coordinated evaluation and treatment is the most effective way to manage patients with pancreatic cancer.

Cited by

• CXCR2 blockade overcomes the NETosis-mediated resistance to MEK inhibition in pancreatic cancer models
• Advances in pancreatic cancer research: Moving towards early detection
• Cancer stem cells: Involvement in pancreatic cancer pathogenesis and perspectives on cancer therapeutics
• Pancreas [wikipedia]
• Pancreatic cancer [wikipedia]
• Role of pancreatic stellate cells in chemoresistance in pancreatic cancer. [europepmc]
• The early detection of pancreatic cancer: what will it take to diagnose and treat curable pancreatic neoplasia? [europepmc]
• Current progress in immunotherapy for pancreatic cancer. [europepmc]
• CYP3A5 mediates basal and acquired therapy resistance in different subtypes of pancreatic ductal adenocarcinoma. [europepmc]
• Pancreatic Cancer Epidemiology, Detection, and Management. [europepmc]
• KRAS Mutant Pancreatic Cancer: No Lone Path to an Effective Treatment. [europepmc]
• Cancer-associated fibroblast-derived annexin A6+ extracellular vesicles support pancreatic cancer aggressiveness. [europepmc]
• Gold Nanoparticle Reprograms Pancreatic Tumor Microenvironment and Inhibits Tumor Growth. [europepmc]
• Alpha-enolase (ENO1) controls alpha v/beta 3 integrin expression and regulates pancreatic cancer adhesion, invasion, and metastasis. [europepmc]
• Hypoxia-inducible factor-2α promotes tumor progression and has crosstalk with Wnt/β-catenin signaling in pancreatic cancer. [europepmc]
• Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma. [europepmc]
• KRAS: The Critical Driver and Therapeutic Target for Pancreatic Cancer. [europepmc]
• Is a Pathological Complete Response Following Neoadjuvant Chemoradiation Associated With Prolonged Survival in Patients With Pancreatic Cancer? [europepmc]
• Survival in Locally Advanced Pancreatic Cancer After Neoadjuvant Therapy and Surgical Resection. [europepmc]
• Real-time Genomic Characterization of Advanced Pancreatic Cancer to Enable Precision Medicine. [europepmc]
• Cancer-associated fibroblasts promote progression and gemcitabine resistance via the SDF-1/SATB-1 pathway in pancreatic cancer. [europepmc]
• Tongue coating microbiome data distinguish patients with pancreatic head cancer from healthy controls. [europepmc]
• Defining and Predicting Early Recurrence in 957 Patients With Resected Pancreatic Ductal Adenocarcinoma. [europepmc]
• Circulating Tumor DNA as a Clinical Test in Resected Pancreatic Cancer. [europepmc]
• Axon Guidance Molecules Promote Perineural Invasion and Metastasis of Orthotopic Pancreatic Tumors in Mice. [europepmc]
• Pembrolizumab in Combination with the Oncolytic Virus Pelareorep and Chemotherapy in Patients with Advanced Pancreatic Adenocarcinoma: A Phase Ib Study. [europepmc]
• circRNAs and Exosomes: A Mysterious Frontier for Human Cancer. [europepmc]
• Current advances and outlooks in immunotherapy for pancreatic ductal adenocarcinoma. [europepmc]
• Identification of a subset of immunosuppressive P2RX1-negative neutrophils in pancreatic cancer liver metastasis. [europepmc]
• Tumor restriction by type I collagen opposes tumor-promoting effects of cancer-associated fibroblasts. [europepmc]

Related

• Multidisciplinary standards of care and recent progress in pancreatic ductal adenocarcinoma
• Pancreatic cancer-improved care achievable
• Curing pancreatic cancer
• Pancreatic adenocarcinoma
• Advances in pancreatic cancer early diagnosis, prevention, and treatment: The past, the present, and the future